Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Beate, Mayer"'
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Antibodies to red blood cells (RBCs) may hemolyze erythrocytes via Fc-mediated phagocytosis or complement-dependent. Complement activation on RBCs can be detected by C3d-direct antiglobulin test (DAT), which is the only test in immune hematology that
Externí odkaz:
https://doaj.org/article/75f8ca1dded04cb3b6e640d885e541ec
Autor:
Nicole Thornton, Vanja Karamatic Crew, Louise Tilley, Carole A. Green, Chwen Ling Tay, Rebecca E. Griffiths, Belinda K. Singleton, Frances Spring, Piers Walser, Abdul Ghani Alattar, Benjamin Jones, Rosalind Laundy, Jill R. Storry, Mattias Möller, Lorna Wall, Richard Charlewood, Connie M. Westhoff, Christine Lomas-Francis, Vered Yahalom, Ute Feick, Axel Seltsam, Beate Mayer, Martin L. Olsson, David J. Anstee
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-11 (2020)
The molecular basis of the clinically important MAM blood group antigen present in most humans is unknown. We identify EMP3 as its encoding gene, establishing MAM as a new blood group system, and demonstrate the role of EMP3 in erythropoiesis through
Externí odkaz:
https://doaj.org/article/e938a7d9bc5f42fa84a3d130a0d92402
Publikováno v:
Cellular Physiology and Biochemistry, Vol 53, Iss 3, Pp 453-464 (2019)
Externí odkaz:
https://doaj.org/article/d84473b34a764e33ae200d90b4588ece
Autor:
Beate Mayer
Publikováno v:
Transfusionsmedizin. 13:88-101
Die medikamentös induzierte Immunhämolyse stellt eine seltene, häufig fulminant und immer wieder letal verlaufende Sonderform der autoimmunhämolytischen Anämie dar. Sie ist wenig bekannt und wird häufig übersehen. Dieser Beitrag stellt die Bes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0fe477806248e5015050431b88b83ba
https://doi.org/10.1055/a-1970-2938
https://doi.org/10.1055/a-1970-2938
Publikováno v:
BMC Pharmacology and Toxicology, Vol 19, Iss 1, Pp 1-7 (2018)
Abstract Background Drug induced immune hemolytic anemia (DIIHA) is a rare complication and often underdiagnosed. DIIHA is frequently associated with a bad outcome, including organ failure and even death. For the last decades, ceftriaxone has been on
Externí odkaz:
https://doaj.org/article/eb7da9840a4242aabdfba2e8b648ed2f
Autor:
Frauke Ringel, Holger Kiesewetter, Beate Mayer, Thilo Bartolmäs, Jalid Sehouli, Abdulgabar Salama
Publikováno v:
Transfusion. 62:2648-2652
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b145c7c1dcb50b79891cefe4adc06dd
https://doi.org/10.1111/trf.17172
https://doi.org/10.1111/trf.17172
Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria
Autor:
Florian Kurth, Tilman Lingscheid, Florian Steiner, Miriam S. Stegemann, Sabine Bélard, Nikolai Menner, Peter Pongratz, Johanna Kim, Horst von Bernuth, Beate Mayer, Georg Damm, Daniel Seehofer, Abdulgabar Salama, Norbert Suttorp, Thomas Zoller
Publikováno v:
Emerging Infectious Diseases, Vol 22, Iss 8, Pp 1381-1386 (2016)
Episodes of delayed hemolysis 2–6 weeks after treatment of severe malaria with intravenous artesunate have been described. We performed a prospective observational study of patients with uncomplicated malaria to investigate whether posttreatment he
Externí odkaz:
https://doaj.org/article/5f183e4c685341d297060a380448f793
Autor:
Florian Kurth, Pinkus Tober-Lau, Tilman Lingscheid, Lara Bardtke, Johanna Kim, Andrea Angheben, Federico G Gobbi, Lena Mbavu, Miriam S Stegemann, Katrin M Heim, Frieder Pfäfflin, Nikolai Menner, Mariana Schürmann, Agata Mikolajewska, Martin Witzenrath, Leif E Sander, Beate Mayer, Thomas Zoller
Publikováno v:
Journal of Travel Medicine. 30
Background Artemisinin-based combination therapy (ACT) for the treatment of malaria is highly effective, well tolerated and safe. Episodes of delayed haemolysis occur in up to 57.9% of patients with severe malaria treated with intravenous artesunate,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::548c28086a6a5846d1dc64048ab10534
https://doi.org/10.1093/jtm/taad001
https://doi.org/10.1093/jtm/taad001
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0198184 (2018)
BACKGROUND:Many patients with immune thrombocytopenia (ITP) may require special attention and long-term treatment. Little is known on the efficacy and tolerability of the drugs used in practice. MATERIAL AND METHODS:We retrospectively reviewed the re
Externí odkaz:
https://doaj.org/article/704042a0c73e4ff3b9df9a23fcd2505d
Autor:
Beate Mayer, Vanja Karamatic Crew, Louise Tilley, Richard Charlewood, Chwen Ling Tay, Vered Yahalom, D J Anstee, Belinda K. Singleton, Abdul Ghani Alattar, Ute Feick, Axel Seltsam, Nicole Thornton, Jill R. Storry, C A Green, Frances A. Spring, Benjamin Jones, Rebecca E. Griffiths, Rosalind Laundy, Piers Walser, Connie M. Westhoff, Mattias Möller, Christine Lomas-Francis, Lorna Wall, Martin L. Olsson
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-11 (2020)
Nature Communications
Nature Communications
The clinically important MAM blood group antigen is present on haematopoietic cells of all humans except rare MAM-negative individuals. Its molecular basis is unknown. By whole-exome sequencing we identify EMP3, encoding epithelial membrane protein 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52a4ccac09c8e060f2829dbf36452cfd
http://link.springer.com/article/10.1038/s41467-020-17060-4
http://link.springer.com/article/10.1038/s41467-020-17060-4